NCT00330148View on ClinicalTrials.gov

Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis

PHASE3TerminatedINTERVENTIONAL
Enrollment

435

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

June 30, 2004

Conditions
Trypanosomiasis, African
Interventions
DRUG

melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d

DRUG

melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d

DRUG

nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d

Trial Locations (1)

Unknown

Omugo Sleeping Sickness Treatment Center, Omugo

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Médecins Sans Frontières, France

OTHER

collaborator

Embassy of France in Uganda

UNKNOWN

collaborator

National Sleeping Sickness Control Program, Uganda

UNKNOWN

lead

Epicentre

OTHER

NCT00330148 - Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis | Biotech Hunter | Biotech Hunter